| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/24/2010 | US20100159458 Method for predicting the response to a therapy |
| 06/24/2010 | US20100159457 System and method for presenting dna binding specificities using specificity landscapes |
| 06/24/2010 | US20100159456 Methods for detecting tcr-gamma gene rearrangement |
| 06/24/2010 | US20100159455 Receptor family profiling |
| 06/24/2010 | US20100159454 HtSNPs FOR DETERMINING A GENOTYPE OF CYTOCHROME P450 1A2, 2A6 AND 2D6, PXR AND UDP-GLUCURONOSYLTRANSFERASE 1A GENE AND MULTIPLEX GENOTYPING METHODS USING THEREOF |
| 06/24/2010 | US20100159453 Genes involved in intestinal inflammatory diseases and use thereof |
| 06/24/2010 | US20100159452 Method For Detecting a Target Nucleic Acid in a Sample |
| 06/24/2010 | US20100159451 Method of detecting interaction between nucleic acid and protein, and apparatus for the same |
| 06/24/2010 | US20100159450 Dpyd gene variants and use thereof |
| 06/24/2010 | US20100159449 Continuous Assay Method for Measuring Receptor- and Ion Channel-Mediated Calcium Response and Subsequent Gene Expression |
| 06/24/2010 | US20100159448 Method for detection and multiple, simultaneous quantification of pathogens by means of real-time polymerase chain reaction |
| 06/24/2010 | US20100159447 Quantitative amplification with a labeled probe and 3' to 5' exonuclease activity |
| 06/24/2010 | US20100159446 Detection Assays and Use Thereof |
| 06/24/2010 | US20100159445 Method for the individual staging of tumor diseases |
| 06/24/2010 | US20100159444 Devices for the detection of multiple analytes in a sample |
| 06/24/2010 | US20100159443 Disease model incorporation into an artificial immune system (ais) |
| 06/24/2010 | US20100159442 Magnetic recognition system |
| 06/24/2010 | US20100159441 Multi-wavelength analyses of sol-particle specific binding assays |
| 06/24/2010 | US20100159440 METHODS FOR IDENTIFYING AGENTS THAT MODULATE p44 |
| 06/24/2010 | US20100159439 Method for combined sequential agent delivery and electroporation for cell structures and use thereof |
| 06/24/2010 | US20100159070 Alcohol Acetyl Transferase Gene and Use Thereof |
| 06/24/2010 | US20100159030 Methods for detecting and modulating the sensitivity of tumor cells to anti-mitotic agents and for modulating turmorgenicity |
| 06/24/2010 | US20100158954 Brucella Melitensis Mutants and Methods |
| 06/24/2010 | US20100158952 Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates |
| 06/24/2010 | US20100158948 Adaptive mutations allow establishment of jfh1-based cell culture systems for hepatitis c virus genotype 4a |
| 06/24/2010 | US20100158947 Permissive cells and uses thereof |
| 06/24/2010 | US20100158934 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
| 06/24/2010 | US20100158931 Novel immunotherapy against several tumors including neuronal and brain tumors |
| 06/24/2010 | US20100158924 Expression of the cysteine protease legumain in vascular and inflammatory diseases |
| 06/24/2010 | US20100158914 Klotho beta |
| 06/24/2010 | US20100158894 Preventive or remedy for er-negative and her2-negative breast cancer and method of screening the same |
| 06/24/2010 | US20100158873 Method for extracting and selecting cells |
| 06/24/2010 | US20100158808 Altered Activity of Toll-Like Receptors |
| 06/24/2010 | US20100158803 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies |
| 06/24/2010 | US20100155668 Semiconductor nanocrystal probes for biological applications and process for making and using such probes |
| 06/24/2010 | DE112008001164T5 Gensignatur der frühen Hypoxie zur Vorhersage des Patientenüberlebens Gene signature of early hypoxia for predicting patient survival |
| 06/24/2010 | DE102008063592A1 Sterile process bag for carrying out a multistage process in a closed system, comprises a carrier matrix with biomolecules to be cleaned in the bag, and an electrode pluggable channel and/or buffer bridges for electro-elution |
| 06/24/2010 | DE102004062386B4 Monacolin K-Biosynthese-Gene Monacolin K biosynthesis genes |
| 06/24/2010 | CA2747718A1 Method for confirming a diagnosis of rolandic epilepsy |
| 06/24/2010 | CA2747322A1 Evaluation of the potential risk of drug induced mood disturbance and suicide: use of a dedicated platform |
| 06/24/2010 | CA2747312A1 Epigenetic markers for the identification of blood sub-cells of type 1 |
| 06/24/2010 | CA2747059A1 Detection conjugate and method for polychromatic analysis |
| 06/24/2010 | CA2746521A1 Cancer specific transcript variants |
| 06/24/2010 | CA2745284A1 Biomarkers for hcv treatment response |
| 06/24/2010 | CA2741592A1 Diagnostic test for mutations in codons 12-13 of human k-ras |
| 06/24/2010 | CA2706317A1 Doc1 compositions and methods for treating cancer |
| 06/23/2010 | EP2199795A2 Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| 06/23/2010 | EP2199794A1 Method for the identification of carcinogenic compounds |
| 06/23/2010 | EP2199793A1 Method of evaluating human dendritic cells and human cell immunotherapeutic agent |
| 06/23/2010 | EP2199413A1 Method of detecting periodontal disease |
| 06/23/2010 | EP2199412A1 Compositions and methods for micro-RNA expression profiling of cancer stem cells |
| 06/23/2010 | EP2199411A1 Epigenetic markers for the identification of CD3 positive T-lymphocytes |
| 06/23/2010 | EP2199410A1 Plasminogen activator inhibitor-1 (PAI-1) Polymorphism useful as indicators of patient outcome |
| 06/23/2010 | EP2199409A2 One step diagnosis by DNA chip |
| 06/23/2010 | EP2199408A1 Method of diagnosing type II diabetes mellitus using multilocus marker, polynucleotide including marker associated with type II diabetes mellitus, and microarray and diagnostic kit including the polynucleotide |
| 06/23/2010 | EP2199407A1 In vitro methods and compositions for the diagnosis and/or treatment of adenocarcinoma |
| 06/23/2010 | EP2199406A1 Intraoperative lymph node assay |
| 06/23/2010 | EP2199405A2 Polypeptides substrates of LRRK2 and uses thereof |
| 06/23/2010 | EP2199404A1 Method of reducing measurement error caused by catalase inhibition by azide |
| 06/23/2010 | EP2199403A1 Concentration measuring apparatus and test strip for the concentration measuring apparatus |
| 06/23/2010 | EP2199393A1 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides |
| 06/23/2010 | EP2199391A1 Factor involved in latent infection with herpesvirus, and use thereof |
| 06/23/2010 | EP2199299A2 Antisense modulation of survivin expression |
| 06/23/2010 | EP2198965A1 Integrated device for automated simultaneous detection of multiple specific targets using nucleic acid amplification |
| 06/23/2010 | EP2198890A1 Combinatorial libraries of monomer domains |
| 06/23/2010 | EP2198381A1 Methods for genetic analysis |
| 06/23/2010 | EP2198306A1 Methods for diagnosing and treating cancers |
| 06/23/2010 | EP2198296A1 Method of using tumour rna integrity to measure response to chemotherapy in cancer patients |
| 06/23/2010 | EP2198293A1 Copy number variation determination, methods and systems |
| 06/23/2010 | EP2198283A1 Method of defining electrodes using laser-ablation and dielectric material |
| 06/23/2010 | EP2198168A1 A system, apparatus and method for applying mechanical force to a material |
| 06/23/2010 | EP2198060A1 Detection of blood group genes |
| 06/23/2010 | EP2198058A2 Marker for the diagnosis of cancer |
| 06/23/2010 | EP2198057A2 Detection of atypical pneumonia |
| 06/23/2010 | EP2198056A2 Method for determining microorganisms |
| 06/23/2010 | EP2198054A1 Use of ccr9, ccl25/teck, and integrin alpha4 in diagnosis and treatment of melanoma metastasis in the small intestine |
| 06/23/2010 | EP2198053A1 Method for categorizing samples containing spermatozoa by molecular profiling |
| 06/23/2010 | EP2198052A1 Method for administering anticoagulation therapy |
| 06/23/2010 | EP2198051A2 Method for detecting ralstonia solanacearum race 3 biovar 2 |
| 06/23/2010 | EP2198050A1 Micrornas differentially expressed in cervical cancer and uses thereof |
| 06/23/2010 | EP2198049A1 Antipsychotic treatment based on snp genotype |
| 06/23/2010 | EP2198048A2 Prediction of qt prolongation based on snp genotype |
| 06/23/2010 | EP2198047A1 Method of detecting the risk of cancer using genetic markers |
| 06/23/2010 | EP2198044A1 Non-thiopurine methyltransferase related effects in 6-mercaptopurine therapy |
| 06/23/2010 | EP2198042A2 Novel markers for bladder cancer detection |
| 06/23/2010 | EP2198041A1 Method and composition for cancer diagnosis and treatment |
| 06/23/2010 | EP2198040A1 In vivo imaging of myelin |
| 06/23/2010 | EP2198000A1 Supramolecular nanostamping printing device |
| 06/23/2010 | EP2197901A1 Soluble fragments of influenza virus pb2 protein capable of binding rna-cap |
| 06/23/2010 | EP2197898A1 Protease inhibition |
| 06/23/2010 | EP2197894A1 Degenerate oligonucleotides and their uses |
| 06/23/2010 | EP2197483A1 Pharmaceuticals compositions comprising actinomycete glycerol acyl derivatives antigens, their process of extraction, and their use against tuberculosis |
| 06/23/2010 | EP2197455A2 Compositions and methods for the identification of inhibitors of retroviral infection |
| 06/23/2010 | EP1872112B1 Multiplex fluorescence detection device having removable optical modules |
| 06/23/2010 | EP1781811B1 Method of detecting mutations in the gene encoding cytochrome p450-2d6 |
| 06/23/2010 | EP1670309B1 Transgenic animals with serious disorders related to alzheimer's disease |
| 06/23/2010 | EP1425423B1 Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles |
| 06/23/2010 | EP1246945B1 Method for identifying a mark applied on a solid body |
| 06/23/2010 | CN201514409U Urine test paper for clinical examination |
| 06/23/2010 | CN201512536U Time-temperature indicator based on lipase reaction |